BCBA/ROSE (BCBA/ROSE)

Buenos Aires Stock Exchange: BCBA/ROSE · ARS

ARS 136

-0.51 (-0.4%)· Recorded snapshot

Market cap	5.8B
Revenue (ttm)	6.8B
Net income (ttm)	183.6M
EPS (ttm)	ARS 4.31
Shares out	42.6M
P/E (trailing)	31.6x
Volume	10,969
Beta	0.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.8B
Net income (ttm): 183.6M
EPS (ttm): ARS 4.31
P/E (trailing): 31.6x
Market cap: 5.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E31.6

P25 n/aP50 n/aP75 n/a

ROE5.5

P25 n/aP50 n/aP75 n/a

ROIC-46.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/ROSE indicators

Market & fundamental data

Available fields

195

Groups with data

Currency

ARS

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Argentina
Country code	AR
Earnings date	2026-12-17
Enterprise value	ARS 8.1B
Exchange	Buenos Aires Stock Exchange
Financial currency	ARS
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1917
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	ARROSE010025
Last earnings date	2026-02-13
Last refreshed	2026-10-29
Last stock split date	2011-11-16
Last stock split type	Forward
Market cap	ARS 5.8B
Next earnings date	2026-12-17
Price	ARS 136.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bcba/ROSE
Website	https://www.rosenbusch.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	3.17%
EV/Earnings	44.32x
EV/FCF	8.44x
EV/Sales	1.19x
FCF / EV yield	11.85%
FCF yield	16.65%
Graham number	132.15269
Graham upside	-2.83%
P/B ratio	0.73x
P/E ratio	31.55x
P/FCF ratio	6.01x
P/OCF ratio	5.95x
P/S ratio	0.85x
Price / tangible book value	0.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-48.55%
EBITDA margin	-46.72%
FCF margin	14.16%
Gross margin	2.65%
Operating margin	-48.55%
Pretax margin	-38.84%
Profit margin	2.69%
ROA	-13.75%
ROA (5Y)	2.53%
ROCE	-18.18%
ROE	5.54%
ROE (5Y)	-57.57%
ROIC	-46.63%
ROIC (5Y)	-28.01%
Tax / revenue	-42.76%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth 10Y	40.69%
FCF growth 3Y	188.85%
FCF growth 5Y	71.57%
Gross profit growth	-87.05%
Gross profit growth 3Y	-59.68%
Gross profit growth 5Y	-16.4%
OCF growth 3Y	76.51%
OCF growth 5Y	70.52%
Revenue growth	-19.51%
Revenue growth (Q)	15.25%
Revenue growth (QoQ)	36.19%
Revenue growth 10Y	44.92%
Revenue growth 3Y	0.13%
Revenue growth 5Y	40.97%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -8.9M
Depreciation and amortization	ARS 125.2M
EBIT	ARS -3.3B
EBITDA	ARS -3.2B
EPS	ARS 4.31
FCF per share	ARS 22.64
Financing cash flow	ARS -1.4B
Free cash flow	ARS 964.4M
Gross profit	ARS 180.7M
Income taxes	ARS -2.9B
Investing cash flow	ARS 126.5M
Net borrowing	ARS -1.4B
Net cash flow	ARS -263.8M
Net income	ARS 183.6M
Operating income	ARS -3.3B
Revenue	ARS 6.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.67
Book value per share	ARS 180.08
Debt / equity	0.39
Debt / FCF	3.18
Interest coverage	-1.73
Long-term assets	ARS 14.7B
Long-term liabilities	ARS 10.3B
Net cash (debt)	ARS -2.1B
Net cash / market cap	-35.94%
Net debt / equity	0.26
Net debt / FCF	2.16
Piotroski F-Score	4
Property, plant and equipment	ARS 14.4B
Shareholders' equity	ARS 7.9B
Tangible book value	ARS 7.7B
Tangible book value per share	ARS 180.08
Total assets	ARS 22.7B
Total cash	ARS 986.4M
Total debt	ARS 3.1B
Total liabilities	ARS 14.7B
WACC	19.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	ARS 8B
Current liabilities	ARS 4.5B
Current ratio	1.79
Inventory turnover	2.07
Net working capital	ARS 3B
Quick ratio	0.89
Working capital	ARS 3.5B
Working capital turnover	2.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	ARS 0.00
Last dividend	ARS 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,689.47%
10Y return CAGR	33.44%
10Y total return	1,689.47%
150-day SMA	ARS 158.06
15Y price change	10,938.96%
15Y return CAGR	36.83%
15Y total return	10,934.78%
1D price change	-0.37%
1M price change	-7.48%
1M total return	-7.48%
1W price change	-5.56%
1W total return	-5.56%
1Y price change	1.87%
1Y return CAGR	1.87%
1Y total return	1.87%
20-day SMA	ARS 142.30
200-day SMA	ARS 172.34
20Y price change	8,645.98%
20Y return CAGR	25.11%
20Y total return	8,733.83%
3M price change	-14.73%
3M total return	-14.73%
3Y price change	184.52%
3Y return CAGR	41.69%
3Y total return	184.52%
50-day SMA	ARS 149.63
50-day SMA vs 200-day SMA	50under200
52-week high	ARS 357.00
52-week high date	2025-11-21
52-week low	ARS 127.00
52-week low date	2025-10-28
5Y price change	1,159.26%
5Y return CAGR	65.98%
5Y total return	1,159.26%
6M price change	-18.07%
6M total return	-18.07%
All-time high	ARS 450.00
All-time high date	2025-06-09
All-time low	ARS 0.28
All-time low date	1999-09-16
Average true range (ATR)	ARS 7.29
Average volume	16.4K
Beta (1Y)	0.08
Beta (2Y)	0.58
Beta (5Y)	0.03
Change from 52-week high	-61.9%
Change from 52-week low	7.09%
Change from all-time high	-69.78%
Change from all-time low	47,804.19%
Change from open	3.82%
Day's gap	-4.03%
Dollar volume	ARS 1.5M
High price	ARS 144.00
Low price	ARS 130.00
Monthly RSI	47.32
Open price	ARS 131.00
Position in 52-week range	42.86%
Previous close	ARS 136.50
Price vs 150-day SMA	-13.96%
Price vs 20-day SMA	-4.43%
Price vs 200-day SMA	-21.09%
Price vs 50-day SMA	-9.11%
Relative volume	0.67
RSI	35.41
Sharpe ratio	0.4
Sharpe ratio (3Y)	1.18
Sharpe ratio (5Y)	1.05
Sortino ratio	0.76
Sortino ratio (3Y)	2.34
Sortino ratio (5Y)	2
Volume	11K
Weekly RSI	35.34
YTD price change	-43.45%
YTD total return	-43.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38.5M
Shares change (QoQ)	0%
Shares outstanding	42.6M

Deeper analysis on BCBA/ROSE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/ROSE report

Is a complete BCBA/ROSE research report available?

No complete published report is available for bcba/ROSE (BCBA/ROSE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/ROSE (BCBA/ROSE)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ROSE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ROSE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ROSE

Frequently asked questions